[ad_1]
Yesterday Saturday, the US Food and Drug Administration granted emergency approval to use a treatment for the emerging virus “Corona” (Covid-19) developed by the biotechnology company “Regeneron”.
And as reported by “Agence France-Presse”, the drug that was approved was used in the treatment of the outgoing president of the United States, Donald Trump, when he was infected with “Covid-19”.
“France Press” quoted US Food and Drug Administration official Stephen Hahn as saying that “allowing these monoclonal antibody treatments can allow patients to avoid hospitalization and reduce the burden on our health care system.”
For his part, Regeneron CEO Leonard Schleifer said that this constitutes “an important step in the fight against” Covid-19, “as high-risk patients in the United States will be able to obtain promising treatment early on. stages of the course of infection “.
The green light was given to treat Regeneron, called “Regen-Cove-2,” which is a combination of 2 antibodies, after it was proven to reduce “Covid-19” cases that require hospitalization or emergency rooms.
[ad_2]
